What is the effect of St. John's wort on cortisol levels?

St. John's Wort Increases Cortisol Metabolism Through CYP3A4 Induction

St. John's wort acts as a potent inducer of the CYP3A4 enzyme system, which accelerates cortisol metabolism and can lead to falsely elevated cortisol measurements in diagnostic testing, but does not directly increase endogenous cortisol production.

Mechanism: CYP3A4 Enzyme Induction

St. John's wort significantly induces hepatic CYP3A4 activity, which is the primary enzyme responsible for metabolizing cortisol to 6β-hydroxycortisol. Multiple studies demonstrate this effect:

• Treatment with St. John's wort for 14 days increased urinary 6β-hydroxycortisol excretion from 254 μg/day to 369 μg/day (P<0.0001), while free cortisol excretion remained unchanged 1
• The ratio of 6β-hydroxycortisol to free cortisol increased significantly from 9.9 at baseline to 14.3 after treatment 1
• Another study showed the urinary 6β-hydroxycortisol/cortisol ratio increased by a mean of 114% (range -25% to 259%) after 14 days of treatment 2

This enzyme induction means cortisol is metabolized more rapidly, but the body compensates by producing more cortisol to maintain homeostasis—the net effect on circulating cortisol levels in steady state is minimal.

Clinical Implications for Diagnostic Testing

The most critical clinical concern is that St. John's wort causes false-positive results on the dexamethasone suppression test (DST), a key diagnostic tool for Cushing's syndrome 3. This occurs because:

• St. John's wort accelerates dexamethasone metabolism through CYP3A4 induction
• Patients metabolize dexamethasone too quickly, leading to inadequate suppression of cortisol
• Post-dexamethasone cortisol levels remain elevated (>1.8 μg/dL), falsely suggesting Cushing's syndrome

Patients must discontinue St. John's wort for at least 2-4 weeks before undergoing DST or other cortisol-based diagnostic testing 3. The guideline explicitly lists St. John's wort alongside phenobarbital and carbamazepine as CYP3A4 inducers that interfere with DST interpretation.

Acute Neuroendocrine Effects

Some research suggests acute, single-dose administration may transiently affect cortisol through central nervous system mechanisms:

• A 600 mg dose caused statistically significant cortisol elevation 30-90 minutes post-administration 4
• A 300 mg dose showed no cortisol effect 4
• These acute effects appear mediated through serotonergic (5-HT2 receptor) mechanisms rather than direct HPA axis stimulation 5

However, these acute effects are clinically insignificant compared to the chronic enzyme induction effects that matter for drug interactions and diagnostic testing.

Key Clinical Pitfalls

1. Do not perform cortisol-based diagnostic testing in patients taking St. John's wort—results will be unreliable for DST and potentially other tests
2. Measuring dexamethasone levels concomitantly with cortisol can identify patients with accelerated metabolism 3, helping distinguish true Cushing's from drug-induced false positives
3. The enzyme induction effect persists for weeks after discontinuation—allow adequate washout time
4. St. John's wort affects multiple drug-metabolizing pathways, creating numerous potential drug interactions beyond cortisol testing

Bottom Line

St. John's wort does not meaningfully increase baseline cortisol production in healthy individuals. Its primary effect is accelerating cortisol (and dexamethasone) metabolism through CYP3A4 induction, which creates significant problems for endocrine diagnostic testing but does not cause hypercortisolism. The clinical relevance is almost entirely related to drug interactions and false-positive diagnostic tests rather than any direct cortisol-elevating effect.